Hearts and Minds Investments Portfolio Falls Nearly 9% in March

MT Newswires Live04-11

Hearts and Minds Investments' (ASX:HM1) portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.

The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.

The investment company also saw the unsuccessful outcome of Opthea's (ASX:OPT) phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts & Minds to write down its investment to zero.

Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2526524680?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-04-11 08:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2526524680","market":"sh","top_or_hot":-1,"title":"Hearts and Minds Investments Portfolio Falls Nearly 9% in March","media":"MT Newswires Live","content":"<html><body><p> Hearts and Minds Investments' (ASX:HM1) portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.</p><p>The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.</p><p>The investment company also saw the unsuccessful outcome of Opthea's (ASX:OPT) phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts &amp; Minds to write down its investment to zero.</p><p>Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hearts and Minds Investments Portfolio Falls Nearly 9% in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHearts and Minds Investments Portfolio Falls Nearly 9% in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-11 08:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hearts and Minds Investments' (ASX:HM1) portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.</p><p>The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.</p><p>The investment company also saw the unsuccessful outcome of Opthea's (ASX:OPT) phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts &amp; Minds to write down its investment to zero.</p><p>Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2526524680","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2526524680","pubTimestamp":1744330743,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hearts and Minds Investments'  portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.The investment company also saw the unsuccessful outcome of Opthea's  phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts & Minds to write down its investment to zero.Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK7067":"生物科技","OPT":"Opthea Ltd","BK7508":"医药生物股","HM1.AU":"HEARTS AND MINDS INVESTMENT","OPT.AU":"OPTHEA LTD"},"translate_title":"Hearts and Minds Investments投资组合3月份下跌近9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HM1.AU":0.9,"OPT":0.9,"OPT.AU":0.9},"content_text":"Hearts and Minds Investments' (ASX:HM1) portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.The investment company also saw the unsuccessful outcome of Opthea's (ASX:OPT) phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts & Minds to write down its investment to zero.Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2526524680"}